
 
 
 
 
 
 
 
 
 What is claimed is: 
   
 1. A monoclonal antibody binding specifically to the human FLT3/FLK2 receptor protein and being produced and released by hybridoma cells that are deposited at the International Depositary Authority DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH Mascheroder Weg 1b, D-38124 Braunschweig, Germany, as of Dec. 19, 1995 under No. DSM ACC2249 in accordance with the Budapest Treaty, and designated 4G8B4B 12. 
 
     
 2. Hybridoma cells deposited at the International Depositary Authority DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH Mascheroder Weg 1b, D-38124 Braunschweig, Germany, as of Dec. 19 1995 under No. DSM ACC2249 in accordance with the Budapest Treaty, and designated 4G8B4B 12. 
 
     
 3. A composition comprising an antibody according to claim 1 and a pharmaceutically acceptable carrier. 
 
     
 4. The composition according to claim 3, wherein the antibody is coupled to a labeling marker. 
 
     
 5. Kit comprising an antibody according to claim 1. 
 
   
 
 
 
 
 
 
 
 
